The Integrated Management of Hypertension in General Hospitals and Community Hospitals.
abdominal circumference
body mass index
diabetes
hypercholesterolemia
hypertension
Journal
Risk management and healthcare policy
ISSN: 1179-1594
Titre abrégé: Risk Manag Healthc Policy
Pays: England
ID NLM: 101566264
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
02
2021
accepted:
24
05
2021
entrez:
28
6
2021
pubmed:
29
6
2021
medline:
29
6
2021
Statut:
epublish
Résumé
We sought to investigate and improve the integrated management of hypertension in general and community hospitals in China. We carried out a cross-sectional study in 90 centers from 15 cities in China from 2017 to 2018. Patients with primary hypertension were included. Of the total 4286 patients included, 43.2% of them controlled blood pressure (BP) below 140/90 mmHg while only 11.5% controlled BP below 130/80 mmHg. The control rate of low-density lipoprotein-C (LDL-C) in patients with concomitant coronary artery disease (CAD), diabetes (DM), and chronic kidney disease (CKD) was 24.7%, 49.4%, and 40.6%, respectively. Thirty-one percent of the DM patients had HbA1c levels greater than 8% while 21.7% of the non-DM patients had HbA1c≥6.5%. The control rate of body mass index (BMI) was 54.4% in men and 59.8% in women. As compared to patients from community hospitals, patients from general hospitals had poorer control of BP<140/90 mmHg (OR 0.63, 95% CI 0.55-0.73, p<0.001), comparatively better attainment of LDL-C, particularly <1.8 mmol/L in CAD (OR 3.25, 95% CI 2.02-5.24, p<0.001), similar control of HbA1c < 8.0% in diabetes (OR 0.64, 95% CI 0.41-1.00, p=0.052) and comparatively worse achievement of BMI<25 kg/m The integrated management of hypertension needs to be improved. Besides LDL-C, the management of BP, blood glucose (BG), and BMI need to be strengthened in not only community hospitals but also general hospitals.
Identifiants
pubmed: 34177280
doi: 10.2147/RMHP.S306735
pii: 306735
pmc: PMC8219293
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2537-2545Informations de copyright
© 2021 Xie et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70
pubmed: 30559232
Eur J Prev Cardiol. 2019 May;26(8):824-835
pubmed: 30739508
J Hypertens. 2020 Jun;38(6):982-1004
pubmed: 32371787
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Cent Eur J Public Health. 2012 Jun;20(2):163-4
pubmed: 22966746
JAMA. 2017 Jun 27;317(24):2515-2523
pubmed: 28655017
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
N Engl J Med. 2010 Mar 25;362(12):1090-101
pubmed: 20335585
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
N Engl J Med. 2015 Nov 26;373(22):2103-16
pubmed: 26551272
Lipids Health Dis. 2019 Dec 27;18(1):229
pubmed: 31881889
Eur J Prev Cardiol. 2016 Apr;23(6):636-48
pubmed: 25687109
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
JAMA. 2013 Sep 4;310(9):948-59
pubmed: 24002281
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96
pubmed: 27353126
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459